Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Sales and DivestituresNet Cash FlowNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

biote (BTMD) Gains from Investment Securities: 2021-2023

Historic Gains from Investment Securities for biote (BTMD) over the last 3 years, with FY2023 value amounting to $13.4 million.

  • biote's Gains from Investment Securities rose 44695.5% to $11.8 million in Q2 2023 from the same period last year, while for Dec 2023 it was $23.6 million, marking a year-over-year increase of 47557.32%. This contributed to the annual value of $13.4 million for FY2023, which is 36157.6% up from last year.
  • According to the latest figures from FY2023, biote's Gains from Investment Securities is $13.4 million, which was up 36157.6% from -$5.1 million recorded in FY2022.
  • biote's 5-year Gains from Investment Securities high stood at $13.4 million for FY2023, and its period low was -$18.8 million during FY2021.
  • For the 3-year period, biote's Gains from Investment Securities averaged around -$3.5 million, with its median value being -$5.1 million (2022).
  • Per our database at Business Quant, biote's Gains from Investment Securities soared by 7276.71% in 2022 and then surged by 36157.6% in 2023.
  • biote's Gains from Investment Securities (Annual) stood at -$18.8 million in 2021, then soared by 72.77% to -$5.1 million in 2022, then skyrocketed by 361.58% to $13.4 million in 2023.
  • Its last three reported values are $13.4 million in FY2023, -$5.1 million for FY2022, and -$18.8 million during FY2021.